Tablets & Capsules

TC0716

Issue link: https://www.e-digitaleditions.com/i/701238

Contents of this Issue

Navigation

Page 42 of 65

Tablets & Capsules July 2016 32I nutra news Dietary supplement industry contributes $122 billion to US economy, says report WASHINGTON, DC—The diet- ary supplement industry has con- tributed $121.6 billion to the US economy, according to a report by the Council for Responsible Nutrition (CRN). It has also created 754,645 jobs, paid $38.4 billion in wages, and contributed nearly $15 billion in fed- eral and state business taxes, not including taxes collected on product sales. You can view the data by state and congressional districts here: http://bit.ly/CRNimpact. NSF expands dietary supplement testing to Europe ANN ARBOR, MI—NSF Erdman Analytics, NSF International's German lab, now offers GMP audits, dietary supplement ingredient testing, DNA sequencing, finished product certifica- tion, and other testing and verification services in Europe. Its NSF Certified for Sport program will screen supple- ments lot by lot for more than 200 substances banned by the World Anti- Doping Agency, USASA, NSF Annex B, and other groups. Valensa makes fish-oil-free omega-3 supplement EUSTIS, FL—Valensa International, a dietary supplement manufacturer based here, began manufacturing its Deep Ocean Caviar supplement, the first Omega-3 phospholipid that doesn't contain fish oil. The supplement is made from herring eggs, algae-sourced astaxanthin, and perilla-seed oil. FDA OKs Algae Life Sciences' 239 structure/function claims IRVINE, CA—Algae Life Sciences, a supplier of algae-based ingredients for the nutraceutical market, received FDA clearance to make 239 structure/ function claims for AstaZine, an astax- anthin product extracted from certi- fied organic microalgae. Supplements may boost antidepressant benefits VICTORIA, AUSTRALIA—Adju- nctive use of certain nutraceuticals may help modulate neurochemical pathways associated with depression, according to a study published in the American Journal of Psychiatry. After searching several databases for clinical trials using adjunctive nutrients to treat depression, researchers from the University of Melbourne say the results of the study suggest that using SAMe (S-Adenosylmethionine), methyfolate, omega-3, and vitamin D along with antidepressants could reduce depressive symptoms. QCFQPXEFTIPXDPN !2- #0ăċŞąāŋąāăĉ -*3+ 31ŋ&'-

Articles in this issue

Links on this page

Archives of this issue

view archives of Tablets & Capsules - TC0716